blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1979331

EP1979331 - TRISUBSTITUTED AMINE COMPOUNDS AS INHIBITORS OF -CHOLESTERYL ESTER TRANSFER PROTEIN CETP [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.01.2013
Database last updated on 10.03.2026
Most recent event   Tooltip12.07.2013Lapse of the patent in a contracting state
New state(s): BG		published on 14.08.2013  [2013/33]
Applicant(s)For all designated states
Mitsubishi Tanabe Pharma Corporation
2-6-18, Kitahama, Chuo-ku, Osaka-shi
Osaka 541-8505 / JP
[2011/48]
Former [2008/42]For all designated states
Mitsubishi Tanabe Pharma Corporation
2-10, Dosho-machi 3-chome Chuo-ku Osaka-shi
Osaka 541-8505 / JP
Inventor(s)01 / NAKAMURA, Yoshinori
c/o Mitsubishi Tanabe Pharma Corporation
2-6-18, Kitahama
Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
02 / HAYASHI, Norimitsu
c/o Mitsubishi Tanabe Pharma Corporation
2-6-18, Kitahama
Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
03 / HIGASHIJIMA, Takanori
c/o Mitsubishi Tanabe Pharma Corporation
2-6-18, Kitahama
Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
04 / KUBOTA, Hitoshi
c/o Mitsubishi Tanabe Pharma Corporation
2-6-18, Kitahama
Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
05 / OKA, Kozo
c/o Mitsubishi Tanabe Pharma Corporation
2-6-18, Kitahama
Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
 [2012/07]
Former [2008/42]01 / NAKAMURA, Yoshinori
c/o Mitsubishi Tanabe Pharma Corporation 2-10, Dosho-machi 3-chome Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
02 / HAYASHI, Norimitsu
c/o Mitsubishi Tanabe Pharma Corporation 2-10, Dosho-machi 3-chome Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
03 / HIGASHIJIMA, Takanori
c/o Mitsubishi Tanabe Pharma Corporation 2-10, Dosho-machi 3-chome Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
04 / KUBOTA, Hitoshi
c/o Mitsubishi Tanabe Pharma Corporation 2-10, Dosho-machi 3-chome Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
05 / OKA, Kozo
c/o Mitsubishi Tanabe Pharma Corporation 2-10, Dosho-machi 3-chome Chuo-ku
Osaka-shi, Osaka 541-8505 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2012/10]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2008/42]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date07707991.130.01.2007
[2008/42]
WO2007JP51861
Priority number, dateJP2006002357231.01.2006         Original published format: JP 2006023572
JP2006032285330.11.2006         Original published format: JP 2006322853
[2008/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007088996
Date:09.08.2007
Language:EN
[2007/32]
Type: A1 Application with search report 
No.:EP1979331
Date:15.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 09.08.2007 takes the place of the publication of the European patent application.
[2008/42]
Type: B1 Patent specification 
No.:EP1979331
Date:07.03.2012
Language:EN
[2012/10]
Search report(s)International search report - published on:EP09.08.2007
ClassificationIPC:C07D239/46, C07D239/48, C07D401/04, C07D401/12, C07D403/12, C07D405/12, C07D413/12, A61K31/505, A61P3/06
[2008/42]
CPC:
C07D239/47 (EP,US); A61K31/505 (KR); A61P1/16 (EP);
A61P11/00 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P19/00 (EP); A61P25/00 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P33/12 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61P9/00 (EP);
A61P9/06 (EP); A61P9/10 (EP); A61P9/12 (EP);
C07D239/42 (EP,US); C07D239/46 (KR); C07D239/48 (EP,US);
C07D239/52 (EP,US); C07D239/56 (EP,US); C07D257/06 (EP,US);
C07D401/04 (EP,US); C07D403/12 (EP,US); C07D405/12 (EP,KR,US);
C07D413/12 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/42]
TitleGerman:TRISUBSTITUIERTE AMINVERBINDUNGEN ALS INHIBITOREN DES CHOLESTERYLESTERTRANSFERPROTEINS CETP[2008/42]
English:TRISUBSTITUTED AMINE COMPOUNDS AS INHIBITORS OF -CHOLESTERYL ESTER TRANSFER PROTEIN CETP[2008/42]
French:COMPOSÉS AMINE TRISUBSTITUÉS UTILISÉS COMME INHIBITEURS DE LA PROTÉINE DE TRANSFERT D'ESTER DE CHOLESTÉRYLE (CETP)[2008/42]
Entry into regional phase23.07.2008National basic fee paid 
23.07.2008Designation fee(s) paid 
23.07.2008Examination fee paid 
Examination procedure23.07.2008Amendment by applicant (claims and/or description)
23.07.2008Examination requested  [2008/42]
05.08.2009Despatch of a communication from the examining division (Time limit: M06)
03.02.2010Reply to a communication from the examining division
29.07.2011Communication of intention to grant the patent
21.11.2011Fee for grant paid
21.11.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.08.2009
Opposition(s)10.12.2012No opposition filed within time limit [2013/07]
Fees paidRenewal fee
28.01.2009Renewal fee patent year 03
26.01.2010Renewal fee patent year 04
25.01.2011Renewal fee patent year 05
24.01.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY07.03.2012
CZ07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
RO07.03.2012
SI07.03.2012
SK07.03.2012
BG07.06.2012
IS07.07.2012
[2013/33]
Former [2012/50]CY07.03.2012
CZ07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
RO07.03.2012
SI07.03.2012
SK07.03.2012
IS07.07.2012
Former [2012/49]CY07.03.2012
CZ07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
RO07.03.2012
SI07.03.2012
IS07.07.2012
Former [2012/48]CY07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
Former [2012/41]CY07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
Former [2012/39]FI07.03.2012
LT07.03.2012
LV07.03.2012
Former [2012/37]FI07.03.2012
LT07.03.2012
Former [2012/33]LT07.03.2012
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.